SE9904289D0 - Method and camposition for the treatment of adenovairal ocular infections - Google Patents
Method and camposition for the treatment of adenovairal ocular infectionsInfo
- Publication number
- SE9904289D0 SE9904289D0 SE9904289A SE9904289A SE9904289D0 SE 9904289 D0 SE9904289 D0 SE 9904289D0 SE 9904289 A SE9904289 A SE 9904289A SE 9904289 A SE9904289 A SE 9904289A SE 9904289 D0 SE9904289 D0 SE 9904289D0
- Authority
- SE
- Sweden
- Prior art keywords
- camposition
- treatment
- ocular infections
- adenoviral
- adenoviral ocular
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7012—Compounds having a free or esterified carboxyl group attached, directly or through a carbon chain, to a carbon atom of the saccharide radical, e.g. glucuronic acid, neuraminic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/727—Heparin; Heparan
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Dermatology (AREA)
- Pulmonology (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Gastroenterology & Hepatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Neurology (AREA)
- Diabetes (AREA)
- Biomedical Technology (AREA)
- Rheumatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Neurosurgery (AREA)
- Zoology (AREA)
- Marine Sciences & Fisheries (AREA)
- Endocrinology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Otolaryngology (AREA)
Priority Applications (11)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9904289A SE9904289D0 (sv) | 1999-11-26 | 1999-11-26 | Method and camposition for the treatment of adenovairal ocular infections |
EP00982008A EP1231925B1 (en) | 1999-11-26 | 2000-11-23 | Method and composition for the treatment of adenoviral ocular infections |
AT00982008T ATE297211T1 (de) | 1999-11-26 | 2000-11-23 | Verfahren und zusammensetzung zur behandlung von adenovirale augeninfektionen |
CNB008161739A CN100566722C (zh) | 1999-11-26 | 2000-11-23 | 治疗腺病毒眼感染的方法和组合物 |
DE60020729T DE60020729T2 (de) | 1999-11-26 | 2000-11-23 | Verfahren und zusammensetzung zur behandlung von adenovirale augeninfektionen |
PCT/SE2000/002313 WO2001037846A1 (en) | 1999-11-26 | 2000-11-23 | Method and composition for the treatment of adenoviral ocular infections |
AU19086/01A AU1908601A (en) | 1999-11-26 | 2000-11-23 | Method and composition for the treatment of adenoviral ocular infections |
JP2000359325A JP4559613B2 (ja) | 1999-11-26 | 2000-11-27 | アデノウイルス眼性感染の治療のための方法および組成物 |
HK03104387.0A HK1052139B (zh) | 1999-11-26 | 2003-06-18 | 治療腺病毒眼感染的方法和組合物 |
US10/997,955 US7528113B2 (en) | 1999-11-26 | 2004-11-29 | Method and composition for the treatment of adenoviral ocular infections |
AU2007202447A AU2007202447B2 (en) | 1999-11-26 | 2007-05-29 | Net as regulator of angiogenic expression |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9904289A SE9904289D0 (sv) | 1999-11-26 | 1999-11-26 | Method and camposition for the treatment of adenovairal ocular infections |
Publications (1)
Publication Number | Publication Date |
---|---|
SE9904289D0 true SE9904289D0 (sv) | 1999-11-26 |
Family
ID=20417870
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE9904289A SE9904289D0 (sv) | 1999-11-26 | 1999-11-26 | Method and camposition for the treatment of adenovairal ocular infections |
Country Status (10)
Country | Link |
---|---|
US (1) | US7528113B2 (xx) |
EP (1) | EP1231925B1 (xx) |
JP (1) | JP4559613B2 (xx) |
CN (1) | CN100566722C (xx) |
AT (1) | ATE297211T1 (xx) |
AU (2) | AU1908601A (xx) |
DE (1) | DE60020729T2 (xx) |
HK (1) | HK1052139B (xx) |
SE (1) | SE9904289D0 (xx) |
WO (1) | WO2001037846A1 (xx) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2116140A1 (en) * | 2008-05-08 | 2009-11-11 | Nestec S.A. | Sialic acid to support the immune system in the elderly |
KR101116868B1 (ko) * | 2008-10-20 | 2012-02-29 | 성균관대학교산학협력단 | 안질환의 예방 또는 치료용 조성물 |
EP2364139A2 (en) | 2008-11-10 | 2011-09-14 | Life Science Nutrition AS | Ngna compositions and methods of use |
MY155507A (en) | 2009-07-07 | 2015-10-30 | Adenovir Pharma Ab | Antiviral compounds |
KR20160073372A (ko) | 2013-08-28 | 2016-06-24 | 아데노비르 파마 에이비 | 다가의 시알산 유도체 |
CN104586642A (zh) * | 2015-02-06 | 2015-05-06 | 武汉中科光谷绿色生物技术有限公司 | N-乙酰神经氨酸单体、n-乙酰神经氨酸水合物或n-乙酰神经氨酸盐在个人护理用品中的应用 |
CN108904633A (zh) * | 2018-10-19 | 2018-11-30 | 长沙浩然医疗科技有限公司 | 一种改善视力的眼膏及其制备方法 |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4522803A (en) | 1983-02-04 | 1985-06-11 | The Liposome Company, Inc. | Stable plurilamellar vesicles, their preparation and use |
AU649110B2 (en) * | 1991-03-07 | 1994-05-12 | Mect Corporation | Pharmaceutical preparation |
GB2261372A (en) | 1991-11-15 | 1993-05-19 | Gregor Reid | Lactobacillus and skim milk compositions for prevention of urogenital infection |
US6235313B1 (en) | 1992-04-24 | 2001-05-22 | Brown University Research Foundation | Bioadhesive microspheres and their use as drug delivery and imaging systems |
US5858698A (en) | 1994-04-21 | 1999-01-12 | University Of Alberta | Methods for detection of enteropathogenic e. coli |
AUPM623994A0 (en) * | 1994-06-15 | 1994-07-07 | Biomolecular Research Institute Limited | Antiviral dendrimers |
JP3141693B2 (ja) * | 1994-08-16 | 2001-03-05 | ダイキン工業株式会社 | シアル酸の9位をフッ素で置換したガングリオシドgm3類縁体及びその中間体 |
US5962311A (en) * | 1994-09-08 | 1999-10-05 | Genvec, Inc. | Short-shafted adenoviral fiber and its use |
DE19547972A1 (de) * | 1995-12-21 | 1997-07-10 | Weropharm Gmbh | Heparin zur Prophylaxe und akuten Therapie der allergischen Konjunktivitis |
CN1211189A (zh) | 1996-02-14 | 1999-03-17 | 普罗克特和甘保尔公司 | 含衍自杜鹃花科植物的物质和乳酸菌生长因子的,用于泌尿生殖系统和肠道疾病的组合物 |
ES2127110B1 (es) | 1996-05-24 | 1999-12-01 | Univ Valladolid | Procedimiento para variar las propiedades electricas del moco ocular humano y de sustitutos para uso oftalmico. |
US5719020A (en) * | 1996-09-25 | 1998-02-17 | Oklahoma Medical Research Foundation | 4,7-dialkoxy N-acetylneuraminic acid derivatives and methods for detection of influenza type A and B viruses in clinical specimens |
WO1998048817A1 (en) | 1997-05-01 | 1998-11-05 | Cytel Corporation | Use of sialyl galactosides and related compounds as anti-angiogenic agents |
US20050201952A1 (en) * | 1998-01-29 | 2005-09-15 | Yash Sharma | Treatment and prevention of viral hepatitis infections |
WO1999067283A2 (en) * | 1998-06-24 | 1999-12-29 | University Of Dundee | Two-kinase domain mitogen- and stress-activated protein kinases and uses thereof |
AT408946B (de) | 1999-02-18 | 2002-04-25 | Immuno Ag | Verwendung von orosomucoid zur herstellung einer pharmazeutischen präparation |
-
1999
- 1999-11-26 SE SE9904289A patent/SE9904289D0/xx unknown
-
2000
- 2000-11-23 AU AU19086/01A patent/AU1908601A/en not_active Abandoned
- 2000-11-23 WO PCT/SE2000/002313 patent/WO2001037846A1/en active IP Right Grant
- 2000-11-23 AT AT00982008T patent/ATE297211T1/de not_active IP Right Cessation
- 2000-11-23 EP EP00982008A patent/EP1231925B1/en not_active Expired - Lifetime
- 2000-11-23 CN CNB008161739A patent/CN100566722C/zh not_active Expired - Fee Related
- 2000-11-23 DE DE60020729T patent/DE60020729T2/de not_active Expired - Lifetime
- 2000-11-27 JP JP2000359325A patent/JP4559613B2/ja not_active Expired - Fee Related
-
2003
- 2003-06-18 HK HK03104387.0A patent/HK1052139B/zh not_active IP Right Cessation
-
2004
- 2004-11-29 US US10/997,955 patent/US7528113B2/en not_active Expired - Fee Related
-
2007
- 2007-05-29 AU AU2007202447A patent/AU2007202447B2/en not_active Ceased
Also Published As
Publication number | Publication date |
---|---|
DE60020729T2 (de) | 2006-05-11 |
AU2007202447A1 (en) | 2007-06-21 |
AU2007202447B2 (en) | 2010-03-11 |
JP4559613B2 (ja) | 2010-10-13 |
AU1908601A (en) | 2001-06-04 |
JP2001151701A (ja) | 2001-06-05 |
EP1231925A1 (en) | 2002-08-21 |
EP1231925B1 (en) | 2005-06-08 |
CN1399552A (zh) | 2003-02-26 |
CN100566722C (zh) | 2009-12-09 |
ATE297211T1 (de) | 2005-06-15 |
US7528113B2 (en) | 2009-05-05 |
DE60020729D1 (de) | 2005-07-14 |
HK1052139B (zh) | 2010-04-23 |
US20050080041A1 (en) | 2005-04-14 |
WO2001037846A1 (en) | 2001-05-31 |
HK1052139A1 (en) | 2003-09-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PT1333887E (pt) | Metodo de tratamento de desordens musculares | |
EA200201263A1 (ru) | СПОСОБЫ ЛЕЧЕНИЯ ИНФЕКЦИЙ, ВЫЗЫВАЕМЫХ ВИРУСОМ ГЕПАТИТА ДЕЛЬТА, С ИСПОЛЬЗОВАНИЕМ β-L-2'-ДЕЗОКСИНУКЛЕОЗИДОВ | |
ATE364386T1 (de) | (s,s)-reboxetine zur behandlung von chronischen erschöpfungssyndrom | |
BR9913406A (pt) | Processo de tratamento de infecção causada por pelo menos um vìrus da famìlia flaviviridae e de doença associada com a citada infecção em um hospedeiro vivo possuindo a citada infecção | |
TR200002739T2 (tr) | Üst solunum problemlerinin tedavisinde ksilitol kompozisyonları | |
BR9710768A (pt) | Composto composi-Æo e processos para tratamento de infec-{es bacterianas em um mamifero hospedeiro com necessidade de tal tratamento e para prepara-Æo de 6-0-metileritromicina forma i | |
MY119375A (en) | Treatment of tinnitus using neuroprotective agents | |
DK1059934T3 (da) | Matrixproteinpræparater til sårheling | |
BR9105783A (pt) | Polipeptidio,processo para o tratamento em vidro de neuronios e composicoes celular e farmaceutica | |
ES2114073T3 (es) | Regeneracion del higado inducida por morfogenes. | |
SE9904289D0 (sv) | Method and camposition for the treatment of adenovairal ocular infections | |
NO980923L (no) | Optisk aktivt fenylpyrimidin-derivat som analgetisk middel | |
DK1237562T3 (da) | Fremgangsmåde til fremstilling af mikania-ekstrakter, som indeholder mikanolid og dihydromikanolid, og anvendelse i behandlingen af prolifererende sygdomme | |
EP1185283A4 (en) | NEW THERAPEUTIC USE OF A VIRAL INJECTION MODULATING PROTEIN TO PREVENT EXHAUST FROM FOREIGN TRANSPLANTS | |
DK1152760T3 (da) | Anvendelse af 4-aminopyridin til behandling af perifere neuropatier | |
ATE554793T1 (de) | Konjugat | |
ATE268170T1 (de) | Verwendung von bernsteisäure oder deren salze zur behandlung von insulinresistenz | |
ATE241640T1 (de) | Fusidinsäure-derivate | |
JP2002533400A5 (xx) | ||
TR200000728T2 (tr) | Kronik hepatit C' nin tedavisinde IFN-alfa ve amantadin kullanımı. | |
AU2396900A (en) | Treatment and prevention of hiv and other viral infections | |
BR0015424A (pt) | Análogos de ácido hidroxieicosatetraenóico e, métodos de seu uso em tratamento de distúrbios de olho seco | |
DE60121449D1 (de) | Behandlung von hepatitis c mit thymosin und pegyliertem interferon | |
UA33545A (uk) | Спосіб лікування дакріоциститу | |
WO2003059334A3 (en) | Gemcitabine in the treatment of smallpox |